Geri Dön

Bio-adhesive polymers containing liposomes for ded treatment

Başlık çevirisi mevcut değil.

  1. Tez No: 643900
  2. Yazar: DUYGU ACAR
  3. Danışmanlar: AR.GÖR. DANIŞMAN YOK
  4. Tez Türü: Doktora
  5. Konular: Polimer Bilim ve Teknolojisi, Polymer Science and Technology
  6. Anahtar Kelimeler: dry eye, artificial tear, in situ gelling, bioadhesion, nanotechnology
  7. Yıl: 2019
  8. Dil: İngilizce
  9. Üniversite: Aston University
  10. Enstitü: Yurtdışı Enstitü
  11. Ana Bilim Dalı: Belirtilmemiş.
  12. Bilim Dalı: Belirtilmemiş.
  13. Sayfa Sayısı: 193

Özet

Dry eye disease (DED) is a prevalent and multifactorial pathology of the ocular surface affecting 5-50% of the world's population.1 The disease is characterized by a loss of homeostasis of the tear film and it may manifest with ocular symptoms such as dryness and burning.2,3 Tear hyperosmolarity and tear film instability constitute the core mechanisms in DED pathophysiology.4 Recently, neutrophil extracellular traps (NETs) have also been postulated to play a role in the pathogenesis of the disease.5,6 Artificial tears constitute the first-line therapy for mild dry eye.7 Nonetheless, most of these ophthalmic formulations in the market supplement only the aqueous phase of the tear film, providing primarily symptomatic relief. Furthermore, artificial tears have drawbacks such as short ocular residence time.8 Objectives and Results Objective-1: Development of artificial tear formulations containing novel components, with suitable physicochemical properties, optimum tolerance, and extended ocular residence time. Liposomes were utilized to replenish the lipids of the tear film and bioadhesive and/or in situ gelling polymers (hydroxypropyl methylcellulose and/or gellan gum, respectively) to extend the ocular residence time of the formulations. In addition, antioxidants (vitamins A, C, and E), osmoprotectants (levocarnitine and trehalose), or antidessicants (trehalose) were incorporated into the formulations for their potential beneficial effects in DED treatment. The neutral to slightly alkaline pH (7.0–7.6), surface tension (44.6–48.7 mN/m), viscosity (3.6–12.1 mPa.s), slight hypotonicity (222.7–272.7 mOsm/L), and liposome size (191.0–200.1 nm) exhibited by the formulations in the physicochemical characterization were considered suitable for topical ophthalmic administration. Formulations containing gellan gum produced viscoelastic gels with shear-thinning properties and suitable viscosities (2.8–3.0 mPa.s). In vivo tolerance studies (in rabbits) showed that the formulations resulted well tolerated. Objective-2: Development of novel tools to evaluate the efficacy of the artificial tear formulations. An in vivo dry eye model and an ex vivo dry eye model were developed. Dry eye was induced in rabbits with topical administration of the preservative benzalkonium chloride (BAK) at 0.1% for 15 days. Dry eye signs including corneal damage, goblet cell loss, and impairments in the conjunctival epithelium were observed in animals after the BAK treatment. Furthermore, a complete ex vivo porcine anterior eye model (Aston Biological Anterior Eye Model) was optimized by adjusting the irrigation frequency of the eyes with a tear analogue. Objective-3: Efficacy studies of the novel artificial tear formulations. Preliminary studies. Preliminary efficacy studies of one of the novel formulations, composed of an in situ gelling polymer (gellan gum 0.25%), a bioadhesive polymer (hydroxypropyl methylcellulose 0.12%), osmoprotectants (levocarnitine 0.4% and trehalose 1.68%), an antioxidant (vitamin C 0.01%), electrolytes (sodium chloride 0.05% and potassium chloride 0.05%), and borates (boric acid 0.84% and sodium tetraborate anhydrous 0.08%), were performed in the previously mentioned in vivo and ex vivo DED models, over a period of 21 days and 18 hours, respectively. In the in vivo model, the treatment with the artificial tear promoted significant improvements in the cornea and the conjunctiva at 7 days after continued treatment (significantly reduced fluorescein and cytological scores compared with baseline). In the ex vivo model, the formulation improved the ocular surface with two instillations after 18 hours, though the small sample size did not allow statistical analysis. Objective-4: Assessment of the effects of the novel artificial tear formulations on NET formation as a proof of concept. Excessive amounts and impaired clearance of NETs have been observed on the ocular surface of DED patients and linked with the pathogenesis of the disease.5,6 Effects of the novel artificial tear formulations on NET formation (NETosis) were assessed in neutrophils. The formulations did not increase NET formation in unstimulated neutrophils, demonstrating an optimal tolerance. Furthermore, in neutrophils stimulated with a NETosis inducing agent, all of the formulations reduced NET formation significantly. Conclusions 1. All of the novel artificial tear formulations developed in this thesis, containing different combinations of liposomes (made up of phosphatidylcholine and cholesterol), a bioadhesive polymer (hydroxypropyl methylcellulose), an in situ gelling polymer (gellan gum), osmoprotectants (levocarnitine and trehalose), antioxidants (vitamins A, C, and E), and other formulation excipients (fructose, electrolytes, and borates) demonstrate suitable physicochemical properties for topical ophthalmic administration and are well tolerated in rabbits. 2. Incorporation of gellan gum at 0.25% with electrolytes created artificial tears with in situ gelling properties, capable of producing viscoelastic gels that suggest an extended ocular residence time of the ophthalmic formulations. 3. Twice-daily topical ophthalmic administration of the preservative benzalkonium chloride at 0.1% for 15 days induces significant alterations on the ocular surface of rabbits that are indicative of dry eye disease. The experimental dry eye model can be used as a platform to evaluate the efficacy of artificial tears. 4. According to the preliminary efficacy studies performed in the in vivo dry eye model, the novel artificial tear containing the in situ gelling polymer gellan gum (0.25%), the bioadhesive polymer hydroxypropyl methylcellulose (0.12%), the osmoprotectants levocarnitine (0.4%) and trehalose (1.68%), the antioxidant vitamin C (0.01%), borates (boric acid 0.84% and sodium tetraborate anhydrous 0.08%), and electrolytes (sodium chloride 0.05% and potassium chloride 0.05%) may be beneficial in DED treatment.

Özet (Çeviri)

Özet çevirisi mevcut değil.

Benzer Tezler

  1. Kontrollü salım yapan biyoadezif yeni vajinal ilaç şekilleri üzerinde çalışmalar

    Studies on bioadhesive controlled release vaginal dosage forms

    FATMANUR TUĞCU DEMİRÖZ

    Doktora

    Türkçe

    Türkçe

    2009

    Eczacılık ve FarmakolojiGazi Üniversitesi

    Farmasötik Teknoloji Ana Bilim Dalı

    PROF. DR. FÜSUN ACARTÜRK

  2. Halomonas levan hydrogels for skin tissue engineering applications

    Deri doku mühendisliği uygulamalarına yönelik halomonas levan hidrojellerinin geliştirilmesi

    SİNEM SELVİN SELVİ

    Yüksek Lisans

    İngilizce

    İngilizce

    2019

    BiyomühendislikMarmara Üniversitesi

    Biyomühendislik Ana Bilim Dalı

    PROF. DR. EBRU TOKSOY ÖNER

  3. Elektroüretimle nanolif eldesine etki eden faktörlerin ve jelatin-pektin içeren nanoliflerin model gıdaların reolojik özelliklerine etkilerinin incelenmesi

    Investigations on affecting parameters of electrospinning and rheological properties of model food systems containing electrospun gelatin-pectin nanofibers

    ALPARSLAN KUMRU

    Yüksek Lisans

    Türkçe

    Türkçe

    2013

    Gıda Mühendisliğiİstanbul Teknik Üniversitesi

    Gıda Mühendisliği Ana Bilim Dalı

    YRD. DOÇ. DR. FİLİZ ALTAY

  4. Yanık tedavisinde kullanılmak üzere hibrit biyoaktif tekstil ürünlerinin geliştirilmesi

    Development of hybrid bioactive textile products to use in burn treatment

    GİZEM CEYLAN TÜRKOĞLU

    Doktora

    Türkçe

    Türkçe

    2020

    Tekstil ve Tekstil MühendisliğiDokuz Eylül Üniversitesi

    Tekstil Mühendisliği Ana Bilim Dalı

    PROF. DR. AYŞE MERİH SARIIŞIK

    DOÇ. DR. SİNEM YAPRAK KARAVANA

  5. Miselyum esaslı biyokompozit üretimi ve ısı yalıtım malzemesi olarak kullanım olanaklarının deneysel çalışmalarla irdelenmesi

    Production of mycelium based biocomposite and examination of usage opportunities as a thermal insulation material with experimental studies

    SEBAHAT SEVDE SAĞLAM

    Yüksek Lisans

    Türkçe

    Türkçe

    2023

    Mimarlıkİstanbul Teknik Üniversitesi

    Mimarlık Ana Bilim Dalı

    PROF. DR. SEDEN ACUN ÖZGÜNLER